Benjamin Krämer

11.5k citations
128 papers · 4.6k · 1 hit paper · h-index 36

Impact in

Papers in

Benjamin Krämer

121 papers receiving 4.4k citations

Benjamin Krämer's Hit Papers

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia 2020 · 807 citations
8070+2+4Years since publication250500750

Peers

Benjamin Krämer
Comparison fields: 5 of 124
  • Hepatology 613
  • Pulmonary and Respiratory Medicine 1.7k
  • Physiology 966
  • Infectious Diseases 622
  • Immunology 688
Replace Jerry Polesel with:
Jerry Polesel Italy
Nicole P. Juffermans Netherlands
Hidesaku Asakura Japan
Y Levo Israel
Mario Pirisi Italy
O. Fausa Norway
Bret A. Lashner United States
Brian Bressler Canada
Sascha David Germany
Marco Contoli Italy
Benjamin Krämer relative to Jerry Polesel Italy Jerry Polesel's profile →
Citations per field
00.5×2.8×
Jerry Polesel · 1×
Citations per year

Countries citing papers authored by Benjamin Krämer

Since Specialization
Citations

This map shows the geographic impact of Benjamin Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Krämer more than expected).

Fields of papers citing papers by Benjamin Krämer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Krämer. The network helps show where Benjamin Krämer may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Krämer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Krämer Line = papers co-authored together Benjamin Krämer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Hit paper breakdown →
2020807
2 2010274
3 2010215
4 2010166
5 2012126
6 2012126
7 2019120
8 2011113
9 2012103
10 2011101
11 2010101
12 2011101
13 201196
14 201789
15 201887
16 201081
17 201671
18 201368
19 201366
20 201066

About Benjamin Krämer

Benjamin Krämer is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Immunology, Physiology and Epidemiology, having authored 128 papers that have together received 4.6k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (50 papers), Respiratory Support and Mechanisms (20 papers), Asthma and respiratory diseases (17 papers), Immune Cell Function and Interaction (17 papers), Inhalation and Respiratory Drug Delivery (13 papers), Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (9 papers) and Allergic Rhinitis and Sensitization (5 papers). The work is most often cited by research in Hepatology (613 citations), Pulmonary and Respiratory Medicine (1.7k citations), Physiology (966 citations), Infectious Diseases (622 citations) and Immunology (688 citations). Benjamin Krämer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Roger Owen, Ulrich Spengler, Jacob Nattermann, Hans Dieter Nischalke, Mark Higgins, Cheryl Lassen, Christian Körner, Tilman Sauerbruch, A Glässner and David Lawrence. Their work appears in journals such as CHEST Journal, Journal of Hepatology, PLoS ONE, Respiratory Medicine and PEDIATRICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact